$4600 | SAVE $1,150 | Single User
$8050 | SAVE $3,450 | Site License
$10350 | SAVE $6,900 | Enterprise License

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017]

Published by Delve Insight: 10 Oct 2017 | 139108 | In Stock

Introduction

DelveInsight’s “Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025.

This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast for 7 major markets. The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast market, as well as treatment algorithm, current treatments & advancements are included.

The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast, providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast 7MM market size is estimated to be USD XX by 2025. The DelveInsight Report will help in enhanced understanding of the Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

• Understanding historical and forecasted epidemiological data for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast covering 7MM from 2015-2025.

• Segment level epidemiology and market split for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast.

• The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast.

• The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast market trends.

• Thorough market distribution based on market share for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast.

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast market.

• To understand the future market competition in the Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast market and Insightful review of the key market drivers and barriers.

• Organize sales and marketing efforts by identifying the best opportunities for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

• Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Table of Contents
for Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017]

  • 1. Report Introduction

    2. Growth Hormone Deficiency (GHD)  Market Overview at a Glance

    2.1. Total Market Share Distribution of Growth Hormone Deficiency (GHD)  for 7 MM in 2016

    2.2. Total Market Share Distribution of Growth Hormone Deficiency (GHD)  for 7 MM in 2025

    3. Growth Hormone Deficiency (GHD) 

    3.1.1. Overview

    3.1.2. Symptoms

    3.1.3. Pathophysiology

    3.1.4. Staging

    3.1.5. Diagnosis

    3.1.6. Treatment

    4. Epidemiology and Patient Population

    4.1.1. United States

    4.1.1.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in United States

    4.1.2. Germany

    4.1.2.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in Germany

    4.1.3. France

    4.1.3.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in France

    4.1.4. Italy

    4.1.4.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in Italy

    4.1.5. Spain

    4.1.5.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in Spain

    4.1.6. United Kingdom

    4.1.6.1. Diagnosed Cases of Growth Hormone Deficiency (GHD)  in United Kingdom

    5. Treatment Algorithm

    5.1.1. Treatment Guidelines/Practices

    6. Marketed Drugs for Growth Hormone Deficiency (GHD) 

    6.1. Drug 1: Company A

    6.1.1. Drug Description

    6.1.2. Mechanism of Action

    6.1.3. Regulatory Milestones

    6.1.4. Advantages & Disadvantages

    6.1.5. Safety and Efficacy

    6.1.6. Product Profile

    6.1.7. Patent Status

    6.2. Drug 2: Company B

    6.2.1. Drug Description

    6.2.2. Mechanism of Action

    6.2.3. Regulatory Milestones

    6.2.4. Advantages & Disadvantages

    6.2.5. Safety and Efficacy

    6.2.6. Product Profile

    6.2.7. Patent Status

    7. Emerging Therapies

    7.1. Drug 3: Company C

    7.1.1. Description

    7.1.2. Regulatory Milestones

    7.1.3. Advantages & Disadvantages

    7.1.4. Product Profile

    7.1.5. Launch Date

    7.1.6. Clinical Development

    7.1.7. Clinical Pipeline Activity

    7.1.8. Ongoing Trials Information

    7.1.9. Clinical Trial by Phase

    7.2. Drug 4: Company B

    7.2.1. Description

    7.2.2. Regulatory Milestones

    7.2.3. Advantages & Disadvantages

    7.2.4. Product Profile

    7.2.5. Launch Date

    7.2.6. Clinical Development

    7.2.7. Clinical Pipeline Activity

    7.2.8. Ongoing Trials Information

    7.2.9. Clinical Trial by Phase

    8. Overview of Total Growth Hormone Deficiency (GHD)  Market (2016 & 2025)

    9. Growth Hormone Deficiency (GHD) : Country-Wise Market Analysis

    9.1. United States

    9.1.1. Historical Market Size (2015-2016)

    9.1.2. Forecasted Market Size (2017-2025)

    9.2. Germany Market Size

    9.2.1. Historical Market Size (2015-2016)

    9.2.2. Forecasted Market Size (2017-2025)

    9.3. France Market Size

    9.3.1. Historical Market Size (2015-2016)

    9.3.2. Forecasted Market Size (2017-2025)

    9.4. United Kingdom Market Size

    9.4.1. Historical Market Size (2015-2016)

    9.4.2. Forecasted Market Size (2017-2025)

    9.5. Spain Market Size

    9.5.1. Historical Market Size (2015-2016)

    9.5.2. Forecasted Market Size (2017-2025)

    9.6. Italy Market Size

    9.6.1. Historical Market Size (2015-2016)

    9.6.2. Forecasted Market Size (2017-2025)

    9.7. Japan Market Size

    9.7.1. Historical Market Size (2015-2016)

    9.7.2. Forecasted Market Size (2017-2025)

    10. Market Drivers

    11. Market Restraints

    12. Appendix

    13. Report Methodology

    14. Consulting Services

    15. Disclaimer

    16. About DelveInsight

    List of Tables

    Table 1: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United States (2015-2025)

    Table 2: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Germany (2015-2025)

    Table 3: Diagnosed Cases Growth Hormone Deficiency (GHD)  in France (2015-2025)

    Table 4: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United Kingdom (2015-2025)

    Table 5: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Spain (2015-2025)

    Table 6: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Italy (2015-2025)

    Table 7: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Japan (2015-2025)

    Table 8: List of Marketed Drugs for Growth Hormone Deficiency (GHD) 

    Table 9: List of Pipeline Phase III Drugs for Growth Hormone Deficiency (GHD) 

    Table 10: Drug 1, Clinical Trials by Zone, 2017

    Table 11: Clinical Trials by Trial status, 2017

    Table 12: Drug 2, Clinical Trials by Zone, 2017

    Table 13: Clinical Trials by Trial status, 2017

    Table 14: Drug 3, Clinical Trials by Zone, 2017

    Table 15: Clinical Trials by Trial status, 2017

    Table 16: United States Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 17: Germany Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 18: France Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 19: United Kingdom Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 20: Spain Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 21: Italy Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Table 22: Japan Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    List of Figures

    Figure 1: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United States (2015-2025)

    Figure 2: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Germany (2015-2025)

    Figure 3: Diagnosed Cases Growth Hormone Deficiency (GHD)  in France (2015-2025)

    Figure 4: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United Kingdom (2015-2025)

    Figure 5: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Spain (2015-2025)

    Figure 6: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Italy (2015-2025)

    Figure 7: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Japan (2015-2025)

    Figure 8: List of Marketed Drugs for Growth Hormone Deficiency (GHD) 

    Figure 9: List of Pipeline Phase III Drugs for Growth Hormone Deficiency (GHD) 

    Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

    Figure 11: Clinical Trials by Trial status, 2017

    Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

    Figure 13: Clinical Trials by Trial status, 2017

    Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

    Figure 15: Clinical Trials by Trial status, 2017

    Figure 16: United States Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 17: Germany Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 18: France Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 19: United Kingdom Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 20: Spain Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 21: Italy Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Figure 22: Japan Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

    Growth Hormone Deficiency (GHD)  Market (7MM)

    Growth Hormone Deficiency (GHD)  Market forecasting

    Growth Hormone Deficiency (GHD)  Sales forecasting

    Growth Hormone Deficiency (GHD)  Market segments

    Growth Hormone Deficiency (GHD)  Epidemiology

    Growth Hormone Deficiency (GHD)  Pipeline products and technologies

    Growth Hormone Deficiency (GHD)  Competitive landscape

    Growth Hormone Deficiency (GHD)  SWOT analysis

    Growth Hormone Deficiency (GHD)  Market Driver’s and barriers

    Growth Hormone Deficiency (GHD)  Key Companies and Funding

List Of Tables
in Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017]

Table 1: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United States (2015-2025)

Table 2: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Germany (2015-2025)

Table 3: Diagnosed Cases Growth Hormone Deficiency (GHD)  in France (2015-2025)

Table 4: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United Kingdom (2015-2025)

Table 5: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Spain (2015-2025)

Table 6: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Italy (2015-2025)

Table 7: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Japan (2015-2025)

Table 8: List of Marketed Drugs for Growth Hormone Deficiency (GHD) 

Table 9: List of Pipeline Phase III Drugs for Growth Hormone Deficiency (GHD) 

Table 10: Drug 1, Clinical Trials by Zone, 2017

Table 11: Clinical Trials by Trial status, 2017

Table 12: Drug 2, Clinical Trials by Zone, 2017

Table 13: Clinical Trials by Trial status, 2017

Table 14: Drug 3, Clinical Trials by Zone, 2017

Table 15: Clinical Trials by Trial status, 2017

Table 16: United States Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 17: Germany Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 18: France Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 19: United Kingdom Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 20: Spain Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 21: Italy Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Table 22: Japan Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

List Of Figures, Charts and Diagrams
in Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017]

Figure 1: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United States (2015-2025)

Figure 2: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Germany (2015-2025)

Figure 3: Diagnosed Cases Growth Hormone Deficiency (GHD)  in France (2015-2025)

Figure 4: Diagnosed Cases Growth Hormone Deficiency (GHD)  in United Kingdom (2015-2025)

Figure 5: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Spain (2015-2025)

Figure 6: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Italy (2015-2025)

Figure 7: Diagnosed Cases Growth Hormone Deficiency (GHD)  in Japan (2015-2025)

Figure 8: List of Marketed Drugs for Growth Hormone Deficiency (GHD) 

Figure 9: List of Pipeline Phase III Drugs for Growth Hormone Deficiency (GHD) 

Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

Figure 11: Clinical Trials by Trial status, 2017

Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

Figure 13: Clinical Trials by Trial status, 2017

Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

Figure 15: Clinical Trials by Trial status, 2017

Figure 16: United States Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 17: Germany Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 18: France Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 19: United Kingdom Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 20: Spain Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 21: Italy Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Figure 22: Japan Market Size of Growth Hormone Deficiency (GHD)  in USD, Million (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

139108 | DIMI0292

Number of Pages

70

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Residential Substance Abuse and Mental Health Facilities Global Market Briefing 2016 Including: Mental Health And Substance Abuse Centers and Residential Intellectual Disability Facilities Historic and Forecast Growth Rate 2011 – 2019 Covering: Asia, Europe, Americas, Middle East & Africa, Oceania
Substance Abuse and Residential Mental Health Facilities Global Market Briefing provides strategists...
05 Dec 2016 by The Business Research Company USD $1,000 More Info
Home Health Care and Residential Nursing Care Services Global Market Briefing 2016 Including: Home Care Providers, Nursing Care Facilities, Orphanages & Group Homes And Retirement Communities Historic and Forecast Growth Rate 2011 – 2019 Covering: Asia, Europe, Americas, Middle East & Africa, Oceania
Home Health Care and Residential Nursing Care Services Global Market Briefing provides strategists, ...
05 Dec 2016 by The Business Research Company USD $1,000 More Info
Physicians and Other Health Practitioners Global Market Briefing 2016 Including: Chiropractors, Optometrists, Physical Therapists, Podiatrists, Primary Care Doctors, Specialist Doctors Historic and Forecast Growth Rate 2011 – 2019 Covering: Asia, Europe, Americas, Middle East & Africa, Oceania
Physicians and Other Health Practitioners Global Market Briefing provides strategists, marketers and...
05 Dec 2016 by The Business Research Company USD $1,000 More Info
Hospitals and Outpatient Care Centers Global Market Briefing 2016 Including: Freestanding Ambulatory Surgical And Emergency Centers, General Medical And Surgical Hospitals, HMO Medical Centers And All Other Outpatient Care Centers Historic and Forecast Growth Rate 2011 – 2019 Covering: Asia, Europe, Americas, Middle East & Africa, Oceania
Hospitals and Outpatient Care Centers Global Market Briefing provides strategists, marketers and sen...
05 Sep 2016 by The Business Research Company USD $1,000 More Info
Market Access Impact: Growth Hormone Deficiency (US)
IntroductionGHD: Has one brand found the winning market access strategy in the US?Market barriers af...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Market Access Impact: Growth Hormone Deficiency (EU5)
IntroductionGHD: Has one brand found the winning market access strategy in Europe?Market barriers af...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
India Pharma Outlook 2016: Milestones to Watch – Growth from Exports and Domestic Getting Better, Implementation of Policies under “Make-in-India”, Overture of A New Ministry
2016 will be a crucial for drug makers and consumers. During ‘Make-in-India’ week in Mumbai, Govt. ...
17 Mar 2016 by MP Advisors USD $1,500 More Info
LARGE CAP PHARMA US & EU OUTLOOK 2016: MAXIMIZING THEIR STRENGTH ON FEWER THERAPY CLASS, PERSONALIZED MEDICINE, NOVEL TARGET AND BIOSIMILARS FOR FUTURE GROWTH
Major pharma companies are continue to improve the productivity by taking different approaches like ...
17 Mar 2016 by MP Advisors USD $2,000 More Info
India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics
Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market’s reacti...
02 Feb 2015 by MP Advisors USD $2,000 More Info
Physician Views: Can Portola's reversal agent act as growth catalyst for novel anticoagulants?
Scope Initial Phase III data released by Portola Pharmaceuticals last week appears to have nudged it...
08 Oct 2014 by FirstWord Pharma USD $695 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data